Exp Mol Med.  2015 Sep;47(9):e184. 10.1038/emm.2015.68.

Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma

• Sohn W
• Kim J
• Kang SH
• Yang SR
• Cho JY
• Cho HC
• Shim SG
• Paik YH

• KMID: 2155438
• DOI: http://doi.org/10.1038/emm.2015.68

Abstract

Recent studies have shown that circulating microRNAs are a potential biomarker in various types of malignancies. The aim of this study was to investigate the feasibility of using serum exosomal microRNAs as novel serological biomarkers for hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). We measured the serum exosomal microRNAs and serum circulating microRNAs in patients with CHB (n=20), liver cirrhosis (LC) (n=20) and HCC (n=20). Serum exosomal microRNA was extracted from 500 mul of serum using an Exosome RNA Isolation kit. The expression levels of microRNAs were quantified by real-time PCR. The expression levels of selected microRNAs were normalized to Caenorhabditis elegans microRNA (Cel-miR-39). The serum levels of exosomal miR-18a, miR-221, miR-222 and miR-224 were significantly higher in patients with HCC than those with CHB or LC (P<0.05). Further, the serum levels of exosomal miR-101, miR-106b, miR-122 and miR-195 were lower in patients with HCC than in patients with CHB (P=0.014, P<0.001, P<0.001 and P<0.001, respectively). There was no significant difference in the levels of miR-21 and miR-93 among the three groups. Additionally, the serum levels of circulating microRNAs showed a smaller difference between HCC and either CHB or LC. This study suggests that serum exosomal microRNAs may be used as novel serological biomarkers for HCC.

MeSH Terms

Adult
Aged
Biomarkers, Tumor/blood/genetics
Carcinoma, Hepatocellular/blood/diagnosis/*genetics
Exosomes/genetics
Female
Gene Expression Profiling
Humans
Liver/pathology
Liver Neoplasms/blood/diagnosis/*genetics
Male
MicroRNAs/blood/*genetics
Middle Aged
Biomarkers, Tumor
MicroRNAs